Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
Announces CDN$3 Million Best-Efforts Private Placement (7/20/2017)
view
Resverlogix Corp.
(RVX:TSX)
Today's Research Reports on GeneNews Limited, Centric Health Corporation, Resverlogix Corp. and TSO3 Inc. (7/26/2017)
view
Resverlogix Corp.
(RVX:TSX)
Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017 (7/25/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio Pharmaceuticals to Report Second Quarter 2017 Financial Results on August 8, 2017 (7/26/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Amgen (AMGN) Stock Falls Despite Q2 Earnings & Sales Beat (7/26/2017)
view
Resverlogix Corp.
(RVX:TSX)
CORRECTION FROM SOURCE: IIROC Trade Halt - Resverlogix Corp. (7/25/2017)
view
Resverlogix Corp.
(RVX:TSX)
IIROC Trade Halt - Resverlogix Corp. (7/25/2017)
view
Resverlogix Corp.
(RVX:TSX)
Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial (7/25/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS (7/25/2017)
view